title: Failing a re-treatment regimen does not predict MDR/XDR tuberculosis: is "blind" treatment dangerous?
authors.forename: G
authors.initials: G
authors.lastname: Badoum
authors.forename: N
authors.initials: N
authors.lastname: Saleri
authors.forename: M S
authors.initials: MS
authors.lastname: Dembélé
authors.forename: M
authors.initials: M
authors.lastname: Ouedraogo
authors.forename: G
authors.initials: G
authors.lastname: Pinsi
authors.forename: K
authors.initials: K
authors.lastname: Boncoungou
authors.forename: V
authors.initials: V
authors.lastname: Bonkoungou
authors.forename: E
authors.initials: E
authors.lastname: Birba
authors.forename: P
authors.initials: P
authors.lastname: Miotto
authors.forename: G B
authors.initials: GB
authors.lastname: Migliori
authors.forename: D M
authors.initials: DM
authors.lastname: Cirillo
authors.forename: A
authors.initials: A
authors.lastname: Matteelli
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002050:Burkina Faso; D002908:Chronic Disease; D015658:HIV Infections / Q000175:diagnosis / Q000276:immunology; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects / Q000302:isolation & purification; D013183:Sputum / Q000382:microbiology*; D017211:Treatment Failure; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents